GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 5 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,083 | -2.4% | 15,844 | +6.3% | 0.00% | – |
| Q2 2023 | $12,384 | +3.9% | 14,906 | +45.1% | 0.00% | – |
| Q1 2023 | $11,918 | -14.9% | 10,274 | -12.0% | 0.00% | – |
| Q2 2022 | $14,000 | -26.3% | 11,681 | +15.8% | 0.00% | -100.0% |
| Q4 2021 | $19,000 | -80.8% | 10,090 | -57.4% | 0.00% | -80.0% |
| Q1 2021 | $99,000 | – | 23,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |